Cistanche

Cistanche has emerging human data, but testosterone, recovery, and muscle claims are still too early and product-specific for recommendation.

Early human signal, high uncertainty strength / recovery / health 5 linked sources Content audit 2026-05-04

Headline Finding

Early RCTs report muscle or locomotive-function signals; testosterone and recovery claims remain preliminary.

Dose Context

Species, extract standardization, and phenylethanoid glycoside content matter. Cistanche deserticola and Cistanche tubulosa are not interchangeable.

Important Caveat

Independent training trials, safety replication, identity testing, and contaminant testing are still needed.

Source Drawer

Linked Research

5 papers and evidence links - audit 2026-05-04

Trial Muscle strength/recovery RCT
Trial Locomotive syndrome RCT
Review Health applications review
Review Cistanche tubulosa review
Systematic review Cistanche systematic review

How To Read This Rating

The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.

Spot An Evidence Issue?

Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.

Report a source or rating issue